FindTrial
Sign In

A prospective, observation study evaluating the outcome of APL patients with minimal residual disease

A prospective, observation study evaluating the outcome of APL patients with minimal residual disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035656
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute promyelocytic leukemia

Interventions

case series:Nil

Sponsors

The First Affiliated Hospital of Medical College of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. APL patients with MRD positive (PML-RARA positive detected by quantitative PCR); 2. Patients aged 18-70 years; 3. Patients with ECoG score of 0 ~ 2; 4. Patients with life expectancy > 8 weeks; 5. Patients who can provide informed consent and understand and comply with the requirements of the study.

Exclusion criteria

Exclusion criteria: The subject of APL relapsed in hematology.

Design outcomes

Primary

MeasureTime frame
overall survival (OS);—

Secondary

MeasureTime frame
minimal residual disease (MRD);complete blood count;response to hyperthermia;—

Countries

China

Contacts

Public ContactHonghu Zhu

The First Affiliated Hospital of Medical College of Zhejiang University

zhuhhdoc@163.com+86 13671232272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026